Cancer Gene Therapy Market - Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2029
Overview
Cancer Gene Therapy Market was valued at US$ 2.13 Bn in 2022 and is expected to reach US$ 9.31 Bn by 2029, at a CAGR of 23.42% during a forecast period.
Cancer gene therapy is a method of treating cancer disease by changing the genetic instructions within an individual’s cells. It is used as a substitute for drugs and surgeries to treat cancer because of the high success rate achieved by trials.
Cancer Gene Therapy Market Dynamics:
Cancer disease occurs because of disrupting the normal cell proliferation and apoptosis process. The advancement in cancer therapy requiresa novel therapeutic agent with a mode of action, mechanisms of cell death and interaction with conventional management. The gene therapy approacheswere developed for the management of cancer, which includesanti-angiogenic gene therapy, pro-apoptotic gene therapy and gene directed-enzyme prodrug therapy.
To Know About The Research Methodology :- Request Free Sample Report
High prevalence of cancer, government initiatives, continuous research & development in the production of cancer gene therapy products, and collaborations to develop gene-therapy products are some of the prominent driving factors behind the global cancer gene therapy market growth. By 2021, greater than 3000 clinical trials were conducted across the globe. Among these trials, greater than 70% are associated with cancer. According to the updated Globocan 2021 estimation, the global cancer burden is indicating that it has risen to 19.3 million cases and more than 10 million cancer deaths in 2021.
On the other hand, thehigh cost of gene therapy treatment, annoying immune responses, and risk allied with the treatment are expected to limit the global cancer gene therapy market growth during the forecast period.
The Liability of Cancer Worldwide:
Cancer is one of the leading causes of death worldwide. In 2022, there were xx.1 million new cases and xx million cancer-related deaths worldwide.
By 2029, the number of new cancer cases is expected to grow to more than 20 million.
The hospital segment is expected to grow at an xx% rate of CAGR during the forecast period. The demand for cancer disease treatment is increasing at an exponential rate. The hospital segment is responding to life-threatening emergencies and many routine health problems that nevertheless require prompt action. High demand for multi-speciality treatment and devices and consumer preference towards innovative surgical procedures performed in hospitals is expected to drive the market growth during the forecast period.
North America is supposed to lead the global cancer gene therapy market.
North America has dominated the global cancer gene therapy market in 2022. The trend is projected to continue its dominance in the near future because of the growth in the geriatric populations, the presence of well-established healthcare infrastructure for the treatment of cancer and technological developments in the gemmotherapy segment. Also, improvedregulatory standards regarding the quality of products, which are used in gene therapy, high investment in R&D activities, adoption of DNA vaccines and acceptance of the gene therapy treatments are some of the driving factors of the regional market growth.
Cancer death in 2021 in the United States:
In 2021, 1,806,590 new cases of cancer have diagnosed in the United States
In 2021, there were more than 16.9 million cancer survivors in the United States. The number of cancer survivors is expected to increase to 19.2 million by 2029.
Asia Pacific is also expected to grow at an xx% rate of CAGR during the forecast period. The presence of the geriatric population is one of the key drivers in the global market. An increase inthe prevalence of cancer, innovation and development in cancer gene therapy are expected to enhance the market regional market growth by 2029.
A number of new cancer cases in 2021 In India:
The objective of the report is to present a comprehensive analysis of the Global Cancer Gene Therapy Marketincluding all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the Global Cancer Gene Therapy Market dynamics, structure by analyzing the market segments and projects the Global Cancer Gene Therapy Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Cancer Gene Therapy Market make the report investor’s guide.
Global Cancer Gene Therapy Market Scope: Inquire before buying
| Global Cancer Gene Therapy Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2022 | Forecast Period: | 2023-2029 |
| Historical Data: | 2018 to 2022 | Market Size in 2022: | US $ 2.13 Bn. |
| Forecast Period 2023 to 2029 CAGR: | 23.42% | Market Size in 2029: | US $ 9.31 Bn. |
| Segments Covered: | by Therapy Type | Gene Induced Immunotherapy Delivery of Cytokines Gene Delivery of Tumor Antigen Gene OncolyticVirotherapy Adenovirus Lentivirus Retro Virus Adeno Associated Virus Herpes Simplex Virus Alpha Virus Vaccinia Virus Simian Virus Others Gene Transfer Naked/Plasmid Vectors Electroporation Sonoportion Magnetofection Gene Gun |
|
| by End User | Hospitals Diagnostics Centers Research Institutes |
||
Global Cancer Gene Therapy Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Global Cancer Gene Therapy Market Key Players
1.Shenzhen SibionoGenetech
2.Glaxosmithkline
3.Oncogenex Pharmaceuticals
4.Bluebird Bio, Inc.
5.Synergene Therapeutics
6.Shanghai Sunway Biotech
7.Biocancell
8.Celgene
9.Merck
10.ZioPharm Oncology
11.MolMed
12.bluebird bio
13.MultiVir
14.Adaptimmune Therapeutics plc
15.Amgen Inc
16.Anchiano Therapeutics
17.Achieve Life Sciences, Inc
18.Advantagene
19.GenVec
20.Cell Genesys
21.Introgen Therapeutics
22.Altor Bioscience
Frequently Asked Questions:
1. Which region has the largest share in Global Cancer Gene Therapy Market?
Ans: North America region held the highest share in 2022.
2. What is the growth rate of Global Cancer Gene Therapy Market?
Ans: The Global market is growing at a CAGR of 23.42% during forecasting period 2023-2029.
3. What is scope of the Global Cancer Gene Therapy market report?
Ans: Global Cancer Gene Therapy Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Cancer Gene Therapy market?
Ans: The important key players in the Global Cancer Gene Therapy Market are – Shenzhen SibionoGenetech, Glaxosmithkline, Oncogenex Pharmaceuticals, Bluebird Bio, Inc., Synergene Therapeutics, Shanghai Sunway Biotech, Biocancell, Celgene, Merck, ZioPharm Oncology, MolMed, bluebird bio, MultiVir, Adaptimmune Therapeutics plc, Amgen Inc, Anchiano Therapeutics, Achieve Life Sciences, Inc, Advantagene, GenVec, Cell Genesys, Introgen Therapeutics, and Altor Bioscience
5. What is the study period of this market?
Ans: The Global Cancer Gene Therapy Market is studied from 2022 to 2029.